Capital Performance Advisors LLP Organon & Co. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Organon & Co. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 360 shares of OGN stock, worth $6,505. This represents 0.0% of its overall portfolio holdings.
Number of Shares
360Holding current value
$6,505% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OGN
# of Institutions
777Shares Held
190MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$589 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$546 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$182 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$163 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V77.43MShares$134 Million0.19% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.6B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...